Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the ...
Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...
A wide-ranging group of 15 nonprofits, humanitarian aid organizations and other funders plan to open this year's Clinton Global Initiative annual meeting Monday morning by announcing new investments ...
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which ...
Black Diamond Therapeutics reports promising initial Phase 2 data for BDTX-1535 in relapsed EGFR-mutant NSCLC patients. With ...